Advertisement

Dicerna Pharmaceuticals, Inc. DRNA

Set alert

Price alert · DRNA

All alert types
38.22 +38.22 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
2.98B
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-19.11
Beta
0.79
Short ratio
0.84
Inst. own
88.54%
Dividend
0.00
Ex-div date
Earnings
Nov 9, 2021
50-d avg
31.45
200-d avg
28.97
1y target
38.25

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for DRNA has not been loaded yet. Try again in a moment.

Revenue & Expenses

Other Income → Expenses: $4.01MExpenses → Selling, General & Admin: $21.99MExpenses → Research & Development: $61.23MExpenses → Income Tax: $810.00KGross Profit → Expenses: $62.95MRevenue → Gross Profit: $62.95MNet Loss → Expenses: $17.07MOther Income$4.01MGross Profit$62.95MNet Loss$17.07MExpenses$84.04MSelling, General & Admin$21.99MResearch & Development$61.23MIncome Tax$810.00KRevenue$62.95M

Period ending Sep 30, 2021 · select a line to chart its history

Income statement

DRNA quarterly income statement
62.95M
62.95M
62.95M
83.23M
61.23M
21.99M
-20.27M
4.00K
810.00K
-17.07M
-17.07M
-17.07M
-17.07M
-0.22
-0.22
-0.22
-16.26M
-16.26M
77.75M
77.75M

Balance sheet

DRNA quarterly balance sheet
165.76M
165.76M
486.45M
399.75M
86.70M
6.23M
589.00M
94.53M
772.06M
4.89M
64.42M
239.29M
59.52M
664.40M
-725.91M
107.66M
107.66M
183.06M
64.42M
550.55M
425.10M
8.32M

Cash flow

DRNA quarterly cash flow
4.65M
2.45M
-55.45M
-17.00K
2.59M
5.88M
5.90M
-63.78M
11.23M
Advertisement